Dr. Oz, the head of CMS, is now calling the plans "CHOICE Arrangements" and asking states to do more to support them.

In other words, the entry of biosimilars into a reference product's market does not guarantee patient savings. Benefit design ...

DeRemer had an inappropriate relationship with a DOL special agent and drank on federal property without proper authorization ...

A Milwaukee hospital alleges CVS used its control of a PBM, specialty pharmacy and third-party administrator to reduce ...

"Understanding the financial challenges LGBTQ+ adults face when accessing health care can help identify persistent gaps in ...

This not only would be the fifth-consecutive year of elevated cost growth but also would be the largest annual increase since ...

Nearly 70% of the estimate rests on payments above an insurer-calculated benchmark that a federal appeals court recently ...

The suits: The new settlement resolves four different federal overtime-pay suits. Each suit was filed on behalf of a group of nurses who had worked for Elevance subsidiaries in areas such as ...

Aon today announced plans to buy USI Insurance Services from KKR for $17 billion in cash. Aon executives talked about how ...

Those areas matter, but one of the more common and overlooked drivers of waste and clinical risk often hides in plain sight across everyday medications: therapy duplication, or situations in which a ...

Simple Healthcare says one of the employers in its AI system test group learned it could cut spending by about 22% by capping ...

The alleged price cuts jeopardize pharmacies' ability to serve their communities, according to Uthmeier's office. For example, a pharmacy outside Orlando saw its reimbursement for one drug drop 45%, ...